PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Lumefantrine manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

artemether + lumefantrine

Tablets 20 mg + 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20275
The company is a well-established pharmaceutical manufacturer with a strong presence in both domestic and international markets. It operates state-of-the-art manufacturing facilities in South Asia, adhering to stringent regulatory standards such as USFDA, UKMHRA, and EU. The company’s extensive R&D center focuses on novel formulation development and preclinical and clinical studies. Internationally, the company exports to numerous countries, including operations across Russia, Africa, Kazakhstan, Myanmar, and Papua New Guinea. With a robust strategy for contract manufacturing, strategic alliances, and licensing, the company is committed to quality, innovation, and expanding its global footprint in the pharmaceutical industry.

artemether + lumefantrine

Oral suspension 40 mg + 240 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

The company is a pharmaceutical manufacturer engaged in the manufacturing of a wide range of pharmaceutical products including tablets, injections, syrups, suspensions and capsules, producing these pharmaceutical products in accordance with established industry norms and supplying them to clients through commercial channels to meet healthcare requirements.

artemether + lumefantrine

Tablets 20 mg + 120 mg, 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087
This company is a manufacturer and exporter of various healthcare products, including pharmaceuticals, nutraceuticals, surgical items, and cosmetics. They specialize in a wide range of dosage forms for their pharmaceutical products, such as tablets, capsules (hard and softgel), oral powders, and liquids. The company focuses on providing affordable generic medications across key regions like the EU and North America. Their commitment to quality is reflected in their state-of-the-art manufacturing facilities that adhere to global standards and GMP certifications. While specific therapy areas and patents aren't mentioned, they highlight a client-centric approach and timely delivery of regulatory documents.

Manufacturer usually replies in 61 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.